Standard
CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC. / Persson, G.; Pohl, M.; Nygard, L.; De Blanck, S. R.; Scherman, J.; Langer, S. W.; Larsen, K. Richter; Clementsen, P. F.; Specht, L.; Fischer, B. M.; Aznar, M. C.; Josipovic, M.
I:
Radiotherapy & Oncology, Bind 133, Nr. S1, 2019, s. S398-S399.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Persson, G, Pohl, M, Nygard, L, De Blanck, SR, Scherman, J
, Langer, SW, Larsen, KR, Clementsen, PF
, Specht, L, Fischer, BM, Aznar, MC
& Josipovic, M 2019, '
CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC',
Radiotherapy & Oncology, bind 133, nr. S1, s. S398-S399.
https://doi.org/10.1016/S0167-8140(19)31193-4
APA
Persson, G., Pohl, M., Nygard, L., De Blanck, S. R., Scherman, J.
, Langer, S. W., Larsen, K. R., Clementsen, P. F.
, Specht, L., Fischer, B. M., Aznar, M. C.
, & Josipovic, M. (2019).
CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC.
Radiotherapy & Oncology,
133(S1), S398-S399.
https://doi.org/10.1016/S0167-8140(19)31193-4
Vancouver
Persson G, Pohl M, Nygard L, De Blanck SR, Scherman J
, Langer SW o.a.
CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC.
Radiotherapy & Oncology. 2019;133(S1):S398-S399.
https://doi.org/10.1016/S0167-8140(19)31193-4
Author
Persson, G. ; Pohl, M. ; Nygard, L. ; De Blanck, S. R. ; Scherman, J. ; Langer, S. W. ; Larsen, K. Richter ; Clementsen, P. F. ; Specht, L. ; Fischer, B. M. ; Aznar, M. C. ; Josipovic, M. / CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC. I: Radiotherapy & Oncology. 2019 ; Bind 133, Nr. S1. s. S398-S399.
Bibtex
@article{9fb99330eb0a4f59a9c417362831d395,
title = "CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC",
author = "G. Persson and M. Pohl and L. Nygard and {De Blanck}, {S. R.} and J. Scherman and Langer, {S. W.} and Larsen, {K. Richter} and Clementsen, {P. F.} and L. Specht and Fischer, {B. M.} and Aznar, {M. C.} and M. Josipovic",
year = "2019",
doi = "10.1016/S0167-8140(19)31193-4",
language = "English",
volume = "133",
pages = "S398--S399",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "S1",
note = "38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) ; Conference date: 26-04-2019 Through 30-04-2019",
}
RIS
TY - ABST
T1 - CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC
AU - Persson, G.
AU - Pohl, M.
AU - Nygard, L.
AU - De Blanck, S. R.
AU - Scherman, J.
AU - Langer, S. W.
AU - Larsen, K. Richter
AU - Clementsen, P. F.
AU - Specht, L.
AU - Fischer, B. M.
AU - Aznar, M. C.
AU - Josipovic, M.
PY - 2019
Y1 - 2019
U2 - 10.1016/S0167-8140(19)31193-4
DO - 10.1016/S0167-8140(19)31193-4
M3 - Conference abstract in journal
VL - 133
SP - S398-S399
JO - Radiotherapy & Oncology
JF - Radiotherapy & Oncology
SN - 0167-8140
IS - S1
T2 - 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)
Y2 - 26 April 2019 through 30 April 2019
ER -
